Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients

Kidney International

Volumn 65, Issue 2, 2004, Pages 682-691

  Rao, Madhumathi ^a   Guo, Daqing ^a   Jaber, Bertrand L ^a   Sundaram, Sumuk ^a   Cendoroglo, Miguel ^a   King, Andrew J ^a   Pereira, Brian J G ^a   Balakrishnan, Vaidyanathapuram S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Biocompatibility; Dialyzer membrane; Dialyzer reuse; ICED score; Karnofsky index; PMNL respiratory burst

Indexed keywords

ALDEHYDE; BLEACHING AGENT; CELLULOSE ACETATE; CELLULOSE TRIACETATE; CHEMOSTERILANT; CUPROPHANE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYSULFONE; SUPEROXIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CELL FUNCTION; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; INSTRUMENT STERILIZATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE FILTER; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RECYCLING; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

EID: 1642561680     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00429.x     Document Type: Article

References (30)

1. US RENAL DATA SYSTEM: 1997 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1997
2. BLOEMBERGEN WE, PORT FK: Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 3:201-207, 1996
3. ROSS R: Atherosclerosis: An inflammatory disease. N Engl J Med 340:115-126, 1999
4. STENVINKEL P, HOLMBERG I, HEIMBURGER O, DICZFALUSY U: A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure: Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 13:2594-2600, 1998
5. WITKO-SARSAT V, FRIEDLANDER M, KHOA TN: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524-2532, 1998
6. KANANI PM, SINKEY CA, BROWNING RL, et al: Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 100:1161-1168, 1999
7. HIRABAYASHI Y, KOBAYASHI T, NISHIKAWA A, et al: Oxidative metabolism and phagocytosis of polymorphonuclear leukocytes in patients with chronic renal failure. Nephron 49:305-312, 1998
8. WARD RA, MCLEISH K: Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 5:1697-1702, 1995
9. JACOBS AJ, WARD RA, WELLHAUSEN SR, MCLEISH KR: Polymorphonuclear leukocytes function during hemodialysis: Relationship to complement activation. Nephron 2:119-124, 1989
10. WARD R: Phagocytic cell function as an index of biocompatibility. Nephrol Dial Transplant 9(Suppl 2):46-56, 1994
11. VANHOLDER R, RINGOIR S, DHONDT A, HAKIM R: Phagocytosis in uremic and hemodialysis patients: A prospective and cross sectional study. Kidney Int 39:320-327, 1991
12. GREENE T, BECK GJ, GASSMAN JJ, et al: Design and statistical issues of the Hemodialysis (HEMO) Study. Control Clin Trials 21:502-525, 2000
13. MISKULIN DC, ATHIENITES NV, YAN G, et al: Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 60:1498-1510, 2000
14. ATHIENITES NV, MISKULIN DC, FERNANDEZ G, et al: Comorbidity assessment in hemodialysis and peritoneal dialysis usine the Index of Coexistent Disease. Semin Dial 13:320-326, 2000
15. ROCCO MV, PARANANDI L, BURROWES JD, et al: Nutritional status in the HEMO Study cohort at baseline. Am J Kidney Dis 39:245-256, 2002
16. VONESH E: Choice of statistical models for assessing the clinical outcomes of the efforts to provide high quality care for the ESRD patient, in Quality Assurance in Dialysis, 2nd ed., edited by Henderson LW, Thuma RS, Dordrecht. The Netherlands, Kluwer Academic Publishers, 1999, pp 39-54
17. CONDLIFFE AM, KITCHEN E, CHILVERS ER: Neutrophil priming: Pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 94:461-71, 1998
18. METCALF JA, GALLIN JI, NAUSEEF WM, ROOT RK: Laboratory Manual of Neutrophil Function, New York, Raven Press, 1986
19. DAUGIRDAS J, DEPNER T, GOTCH F, et al: Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 52(5):1395-1405, 1997
20. SARNAK MJ, JABER BL: Mortality due to sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58:1758-1764, 2000
21. COHEN G, HAAG-WEBER M, HORL W: Immune dysfunction in uremia. Kidney Int 52:S79-S82, 1997
22. HORL WH: Neutrophil function and infections in uremia. Am J Kidney Dis 33:xlv-xlviii, 1999
23. HIMMELFARB J, LAZARUS JM, HAKIM R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 17:271-276, 1991
24. WARD R, SCHMIDT B, BLUMENSTEIN M, GURLAND HJ: Evaluation of phagocytic cell function in an ex vivo model of hemodialysis. Kidney Int 37:776-782, 1990
25. VANHOLDER R: Relationship between biocompatibility and neutrophil function in hemodialysis patients. Adv Ren Replace Ther 3:312-314, 1996
26. CHEUNG AK, AGODOA LY, DAUGIRDAS JT, et al: Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol 10:117-127, 1999
27. LEYPOLDT JK, CHEUNG AK, DEETER RB: Effect of hemodialyzer reuse: Dissociation between clearances of small and large solutes. Am J Kidney Dis 32:295-301, 1998
28. POWE NR, JAAR B, FURTH SL, et al: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55:1081-1090, 1999
29. PORT FK, WOLFE RA, HULBERT-SHEARON TE, et al: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS Dialysis Morbidity and Mortality Study. Am J Kidney Dis 37:276-286, 2001
30. BALAKRISHNAN VS, JABER BL, NATOV SN, et al: Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients. Kidney Int 54:2106-2112, 1998